Lantheus Holdings
Tracked across 2 events · 13 articles · First seen Sep 30, 2025 · Last active Sep 21, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Lantheus is the target, with shareholders receiving a premium and contingent value rights. The company will become privately held, and its products like Pylarify and Definity will be integrated into Curium's operations.
Aug 03, 2026 · 7 articles
Business
Telix Pharmaceuticals agreed to acquire privately held ITM Isotope Technologies Munich in a deal valued at up to $2.35 billion, comprising $1.65 billion upfront plus up to $700 million in contingent milestone payments. The upfront…
Impact: Being acquired by Curium Pharma in an $8 billion deal, a parallel consolidation move that intensifies competition for Telix's expanded radiopharmaceutical platform.
Sep 21, 2026 · 6 articles
45
Curium Pharma acquiring Lantheus Lantheus HoldingsTelix acquires ITM Isotope...
ERGEN INTELLIGENCE
Track Lantheus Holdings live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard